findmyKOL
Clinical trialNCT00000857CompletedPhase 1Interventional

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment65HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Care Center Crs

    Los Angeles, California, United States

  • Usc Crs

    Los Angeles, California, United States

  • Stanford Crs

    Palo Alto, California, United States

  • Ucsf Aids Crs

    San Francisco, California, United States

  • Harbor-Ucla Med. Ctr. Crs

    Torrance, California, United States

  • Northwestern University Crs

    Chicago, Illinois, United States

  • Rush Univ. Med. Ctr. Actg Crs

    Chicago, Illinois, United States

  • Weiss Memorial Hosp.

    Chicago, Illinois, United States

  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic

    Indianapolis, Indiana, United States

  • Beth Israel Deaconess Med. Ctr., Actg Crs

    Boston, Massachusetts, United States

  • Massachusetts General Hospital Actg Crs

    Boston, Massachusetts, United States

  • Ny Univ. Hiv/aids Crs

    New York, New York, United States

  • Univ. of Rochester Actg Crs

    Rochester, New York, United States

  • Unc Aids Crs

    Chapel Hill, North Carolina, United States

  • Hosp. of the Univ. of Pennsylvania Crs

    Philadelphia, Pennsylvania, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
Primary completion
Completion
30 Jun 2001
Last update posted
29 Oct 2021
Registered enrollment
65
Registry id
NCT00000857

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.